Clinical Trial

HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma

Study acronym: HN001
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The study will evaluate the safety and effectiveness of a lower than standard dose of radiation for definitive or adjuvant treatment of head and neck squamous cell carcinomas.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-07-22; most recent amendment 2026-02-03.
Status change: Not Yet Recruiting → Recruiting 2024-10-29
Trial Details
NCT Number NCT05962242
Lead Sponsor University of Virginia
Conditions Squamous Cell Carcinoma of the Oropharynx
Enrollment 90 participants
Start Date 2024-06-28
Primary Completion 2027-11-01 (estimated)
Study Completion 2029-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-05